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Background: Heart failure is a chronic condition that commonly results in frequent 
hospitalizations and increases risk of mortality (Kotb et al., 2015; Ong et al., 2016; 
Pekmezaris et al., 2018). In addition, heart failure places a significant burden on 
healthcare costs and utilization of resources (Hale et al., 2016; Kotb et al., 2015; Ong et 
al., 2016). Measures to reduce heart failure readmissions, mortality, and overall costs are 
needed. Telemedicine interventions may be beneficial in the management of heart failure; 
however, the current research provides unclear and inconclusive findings in regard to the 
effectiveness of telemedicine interventions on heart failure readmissions and mortality 
(Kraai et al., 2016). Aim: The aim of this literature review is to evaluate the impact of 
telemedicine interventions on heart failure readmissions and mortality. Methods: A 
literature review was conducted using five healthcare-related databases for data 
collection. A systematic search process was employed to extract literature that was 
relevant and answered the identified clinical question using keywords and specific 
inclusion and exclusion criteria. A total of 10 studies met inclusion criteria for critical 
appraisal. Results: Study outcomes related to heart failure readmissions and mortality 
were mixed. Limitations of the studies as well as direction for future studies were 
identified. Conclusions: Synthesized findings from this literature review identify that 
telemedicine interventions may improve outcomes in heart failure patients. However, 
further research studies are warranted to evaluate the efficacy of telemedicine on heart 
failure outcomes.  
Keywords: heart failure, telehealth, telemonitoring, telemedicine, readmission, 
mortality, intervention, outcome, 30 day 
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Impact of Telemedicine on Heart Failure Readmissions and Mortality: A Literature 
Review 
Heart failure is a chronic condition leading to progressive, impaired cardiac 
function (Kotb et al., 2015; Pekmezaris et al., 2018). Individuals with heart failure are at 
risk for frequent hospitalizations and have an increased risk of mortality (Kotb et al., 
2015; Ong et al., 2016; Pekmezaris et al., 2018). The negative impact of heart failure on 
healthcare costs and utilization is also a rising concern (Hale et al., 2016; Kotb et al., 
2015; Ong et al., 2016). Issues with accessibility, poor transitions of care and monitoring 
post-hospitalization are factors associated with this increased burden on the healthcare 
system (Koehler et al., 2018; Ong et al., 2016). Interventions aimed at reducing 
readmissions and mortality are warranted and an essential component of heart failure 
management (Koehler et al., 2018). Technological advances have given rise to innovative 
measures utilized in the healthcare setting in an effort to improve health outcomes. 
Numerous telemedicine interventions are available and are currently being used in the 
management of various illnesses including heart failure. These measures have been 
implemented in an effort to reduce disease progression and subsequent hospitalization 
through frequent monitoring and increased follow up (Koehler et al., 2018; Kotb et al., 
2015; Pedone et al., 2015). The utilization of telemedicine in heart failure provides a 
means to remotely care for heart failure patients; therefore, increasing the timeliness of 
care while also improving the quality of the care provided (Koehler et al., 2018). 
Research has shown a potential reduction in heart failure-related hospitalizations, 
morbidity, and mortality through the use of telemonitoring programs (Hale et al., 2016; 
Kotb et al., 2015; Ong et al., 2016; Pedone et al., 2015). Additionally, it is suggested that 
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telemedicine technologies may reduce overall costs related to heart failure (Kotb et al., 
2015; Ong et al., 2016; Pedone et al., 2015). However, findings from current research 
studies are often inconsistent or inconclusive (Koehler et al., 2018; Long et al., 2017; 
Pedone et al., 2015). Moreover, there have been no significant improvements in health 
outcomes among heart failure patients despite these technological advancements (Son et 
al., 2020). Innovative methods to improve the care of patients with heart failure, reduce 
hospital readmissions, and reduce overall mortality are necessary. Further research 
focusing on interventions for heart failure management and dissemination of findings are 
needed to guide healthcare providers to best care for heart failure patients. The purpose of 
this literature review is to identify and synthesize findings related to the impact of 
telemedicine interventions on heart failure readmissions and mortality. Another goal of 
this review is to identify findings that can be used to help guide current and future 
practice related to heart failure management.  
Background 
Prevalence of Heart Failure 
As many as 6 million Americans have been diagnosed with heart failure (Hale et 
al., 2016; Long et al., 2017; Ong et al., 2016; Pekmezaris et al., 2018). Moreover, the 
overall prevalence of heart failure is increasing, with an additional 555,000 individuals 
being diagnosed every year (Hale et al., 2016; Long et al., 2017; Ong et al., 2016; 
Pekmezaris et al., 2018; Son et al., 2020). Additionally, the total number of individuals 
diagnosed with heart failure is projected to increase 46% by the year 2030 (Son et al., 
2020). Older individuals, especially, have a higher incidence of heart failure, with nearly 
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10 out of 1,000 adults aged 65 and older diagnosed (Long et al., 2017; Pekmezaris et al., 
2018; Son et al., 2020). 
Heart Failure Prognosis 
Heart failure patients are frequently hospitalized and are six times more likely to 
be hospitalized compared to those without heart failure (Long et al., 2017; Ong et al., 
2016). Additionally, heart failure patients who are discharged are frequently readmitted 
(Hale et al., 2016; Ong et al., 2016). Research demonstrates that 13% of discharged 
patients are readmitted within 15 days, 25% are readmitted within 30 days, and almost 
50% are readmitted within six months of hospital discharge (Hale et al., 2016). 
Individuals with heart failure are also at an increased risk of mortality, with one in nine 
deaths being attributed to heart failure (Hale et al., 2016; Kotb et al., 2015; Ong et al., 
2016). Lastly, individuals aged 65 and older account for 80% of heart failure 
hospitalizations and 90% of deaths related to heart failure (Son et al., 2020).  
Burden on Costs and Healthcare Utilization 
Heart failure has a tremendous impact on healthcare utilization and expenditure 
(Pekmezaris et al., 2018). Additionally, it has been identified as the leading cause of 
hospital admissions, especially among adults 65 years of age and older (Hale et al., 2016; 
Long et al., 2017). The annual cost of managing heart failure is over $100 billion dollars 
(Pekmezaris et al., 2018). Moreover, roughly 34% of Medicare spending is targeted 
toward heart failure (Long et al., 2017). As a result of the Affordable Care Act, hospitals 
may experience decreased payments from the Centers for Medicare and Medicaid 
Services as a result of excessive readmissions related to heart failure (Long et al., 2017; 
Ong et al., 2016). Furthermore, costs related to heart failure are expected to trend upward, 
 6 
with hospitalizations being a major contributor (Hale et al., 2016; Long et al., 2017; 
Pekmezaris et al., 2018). However, current methods aimed at reducing hospital 
readmissions have proven challenging (Koehler et al., 2018). As a result of the negative 
impact of heart failure on costs and healthcare utilization, identification of specific 
interventions are necessary to reduce this burden on the healthcare system (Long et al., 
2017; Pekmezaris et al., 2018).  
Heart Failure Management 
Self-management is a complex process and a major component in chronic heart 
failure management (Hale et al., 2016; Long et al., 2017). Patients are required to engage 
in self-care behaviors including frequent monitoring of their weight, recording symptoms, 
adhering to medication regimens, and modifying their lifestyle to attain positive health 
outcomes (Son et al., 2020). Research findings suggest that medication adherence is 
directly related to heart failure outcomes (Hale et al., 2016). Poor medication adherence 
ultimately contributes to increased risk for hospitalization and mortality, and increased 
costs (Hale et al., 2016). Many factors contribute to poor medication adherence in heart 
failure patients including complex medication regimens and memory issues among older 
adults (Hale et al., 2016). Measures to improve medication adherence, self-care, and self-
management are necessary to improve outcomes (Hale et al., 2016). Many telehealth 
interventions that have been utilized in the management of heart failure may lead to a 
reduction in hospital readmissions and overall mortality (Hale et al., 2016). However, 
specific telemedicine interventions that can improve these outcomes need to be identified.  
Definitions 
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 Telehealth. Telehealth encompasses delivering healthcare services through 
technological devices (Hale et al., 2016; Pekmezaris et al., 2018). It can be useful for 
communicating, providing education, coordinating care, and enhancing disease self-
management and self-care (Hale et al., 2016; Pekmezaris et al., 2018).  
Telemedicine. Telemedicine incorporates remote care delivery via technology in 
order to provide more accessible healthcare, improve the quality of care provided, and 
reduce healthcare costs (Hale et al., 2016). These interventions may include structured 
telephone support, telemonitoring systems, video monitoring, medication dispensers, 
Bluetooth capable devices that monitor biometrics, and telemedicine systems that allow 
ECG transmissions (Kotb et al., 2015; Long et al., 2017).  
Telemonitoring. Telemonitoring is a telehealth intervention that allows for 
remote monitoring of various measurements from a centralized location to the healthcare 
setting (Hale et al., 2016; Pekmezaris et al., 2018). These measurements can include 
weight, vital signs, and patient-reported symptoms (Hale et al., 2016). Remote 
monitoring interventions provide a means to adjust medication regimens, provide patient 
education, and detect signs of deterioration earlier on (Koehler et al., 2018).  
Clinical Phenomenon of Interest  
The author of this literature review cultivated a spirit of inquiry in which a clinical 
phenomenon of interest was identified (Melnyk & Fineout-Overholt, 2019). The author 
identified a wide range of telemedicine technologies used in the management of heart 
failure that appear promising (Pekmezaris et al., 2018). However, their effectiveness in 
reducing heart failure readmissions and mortality remains unclear (Koehler et al., 2018; 
Long et al., 2017). The clinical phenomenon of interest specific to this literature review is 
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the use of telemedicine and its role in the management of heart failure. Of particular 
interest, is the impact of telemedicine interventions on heart failure readmissions and 
mortality. 
Clinical Question 
A clinical question was developed for this literature review based on the clinical 
phenomenon of interest pertaining to the impact of telemedicine interventions on heart 
failure outcomes. The health outcomes evaluated were heart failure-related readmissions 
and mortality. The clinical question was formatted and structured in PICOT format 
(P=population, I=intervention, C=comparison, O=outcome, T=time) outlined by Melnyk 
and Fineout-Overholt (2019) in an effort to obtain relevant evidence from the current 
literature. The clinical PICO(T) question posed for this literature review was as follows: 
In adult heart failure patients (P), does the use of telemedicine interventions (I) 
compared to standard care without the use of telemedicine interventions (C) impact 
hospital readmissions and overall mortality (O)? 
Clinical Significance for Advanced Practice Providers 
Self-management in heart failure is a complex process. Advanced practice 
providers have a key role in assisting heart failure patients to achieve positive health 
outcomes as they work closely with this patient population. However, there are several 
factors that may hinder effective heart failure management including accessibility and 
poor care transitions post-hospitalization (Long et al., 2017; Ong et al., 2016). 
Additionally, heart failure has been identified as a significant public health issue resulting 
in frequent hospitalizations and increased mortality rates (Pekmezaris et al., 2018). The 
burden on costs and healthcare utilization is also a rising concern. Changes to 
 9 
reimbursements and penalties related to excessive readmissions in heart failure patients 
have mandated healthcare providers to identify effective measures to lower readmission 
rates (Long et al., 2017; Ong et al., 2016; Pekmezaris et al., 2018). These issues require 
advanced practice providers to be knowledgeable about best practices to reduce heart 
failure readmissions, mortality rates, and healthcare costs and utilization while improving 
the overall quality of care for heart failure patients. Therefore, evaluating the 
effectiveness of telemedicine on heart failure outcomes can assist in guiding current 
practice (Long et al., 2017). Additionally, previous studies have identified a potential 
reduction in hospital readmissions among heart failure patients and mortality through 
specific telemedicine interventions (Ong et al., 2016). The use of various telemedicine 
technologies could prove valuable in standardizing care among heart failure patients, 
improving care transitions, increasing access to care, and decreasing hospital readmission 
rates (Long et al., 2017). Thus, the purpose of this literature review is to identify 
telemedicine interventions that may be effective in improving health outcomes among 
heart failure patients.  
Methods 
Search Strategies 
A total of five databases related to medicine, nursing, allied health, and healthcare 
were selected for this literature review. Databases included in the search included 
PubMed, CINAHL Plus (with full text), Nursing and Allied Health Database (Formerly 
ProQuest Nursing and Allied Health Source), Academic Search Premier (ASP), and the 
Cochrane Database of Systematic Reviews. Date ranges included in the database searches 
were limited to publication dates between 2015 and 2020. Refer to Table A1 in the 
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Appendix for further information on the databases utilized in the search process and the 
general subjects covered by the databases selected. The search process was restricted to 
articles that were free, full-text, from scholarly academic journals, were peer-reviewed, in 
the English language, and included the adult (18+) patient population. Refer to Table A1 
in the Appendix for additional search restrictions employed per database. 
Data Abstraction Process 
A systematic and comprehensive search of the literature was conducted utilizing 
the previously mentioned databases. The literature was searched on November 14th, 2020 
and November 15th, 2020 for the most current evidence that would answer the clinical 
PICO(T) question posed (Melnyk & Fineout-Overholt, 2019). Keywords and keyword 
combinations were entered into each database using the Boolean operators. The keywords 
and keyword combinations included in the search process were “heart failure” AND 
“telehealth”, “heart failure” AND “telehealth” OR “telemonitoring” OR “telemedicine” 
AND “readmission” AND “mortality”, “heart failure” AND “telehealth” AND 
“readmission” AND “mortality”, “heart failure” AND “telemedicine” AND 
“intervention” AND “readmission” AND “mortality” AND “outcome”, and “heart 
failure” AND “telemedicine” AND “intervention” AND “readmission” AND “30 day” 
AND “mortality” AND “outcome”. Initial hits from the search were substantial. Thus, 
search results from each database were further narrowed to a manageable number of 
articles utilizing these specific keywords and keyword combinations. Hits of less than 50 
articles as a result of these keywords and keyword combinations were further reviewed 
for inclusion or exclusion based on the criteria used for this literature review. Duplicate 
articles were removed. Refer to Table A2 in the Appendix for detailed information on the 
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data abstraction process and the results from each database using these keywords and 
keyword combinations.  
Literature Review Process 
A total of 15 articles were reviewed for inclusion and exclusion criteria from 
PubMed, 48 from CINAHL, 45 from Nursing and Allied Health, 43 from Academic 
Search Premier, and two articles from the Cochrane Database of Systematic Reviews. 
Specific details related to each study were thoroughly reviewed including study purpose, 
population, setting, sample size, design, level of evidence, variables, instruments, 
interventions as well as primary and secondary outcomes. Studies were limited to either 
level I or level II evidence based on the hierarchy of evidence (Melnyk and Fineout-
Overholt, 2019). Studies that were directly related to the targeted heart failure population, 
incorporated the use of telemedicine modalities, and addressed heart failure-related 
hospital readmissions and mortality rates were included in this literature review. Studies 
were excluded if the heart failure population was not the population of interest and if 
outcomes were evaluated among multiple patient populations or disease processes such 
as COPD. Studies that did not specifically evaluate the impact of telemedicine on heart 
failure readmissions and mortality as a primary or secondary outcome were also 
excluded. Additional studies were excluded if they did not meet the criteria for level I or 
II evidence (Melnyk & Fineout-Overholt, 2019). Furthermore, studies were excluded if 
they involved study designs or study protocols. Refer to Table A3 in the Appendix for 
further details pertaining to the included and excluded studies and the author’s rationale 
for inclusion or exclusion.  
Methodological Assessment 
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A total of 10 articles were yielded from the search process for critical appraisal. 
The studies included five randomized controlled trials. There were two systematic 
reviews and four studies that were a combined systematic review and meta-analysis. 
Studies that were either level I or level II evidence and pertinent to the clinical PICO(T) 
question were retained and evaluated (Melnyk & Fineout-Overholt, 2019). Refer to Table 
A4 in the Appendix for detailed information on the types of studies included in this 
literature review.  
Overall, there were no identified issues with bias within the search process. 
Despite using strategic search methods, it is possible that articles relevant to this literature 
review were not identified due to the specific keywords employed in the search process. 
The keywords utilized may have limited the search results as there are a variety of terms 
used to describe telemedicine as well as a multitude of telemedicine interventions 
available that may not have been specified in the keywords and keyword combinations 
utilized.  
Literature Review  
The following literature review will provide a synthesis of the current available 
evidence pertaining to the clinical phenomenon of interest and answering the clinical 
PICO(T) question posed. This literature review will identify the characteristics of the 
studies included and synthesize findings related to the impact of telemedicine in heart 
failure management and health outcomes. More specifically, this literature review will 
identify findings related to the effect of telemedicine interventions in reducing heart 
failure readmissions and mortality.   
Study Characteristics 
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As previously outlined, there were a total of 10 studies that met the eligibility 
criteria for inclusion and were critically appraised for this literature review. The studies 
yielded were level I or level II evidence and were published between 2015 and 2020. 
There were five randomized controlled trials, two systematic reviews, and four combined 
systematic reviews and meta-analyses. Sample sizes among the studies included in this 
literature review ranged from 25 to 51,014. There were seven studies with sample sizes 
over 1,400. Only three of the studies had sample sizes of less than 200.  
The included studies evaluated a form of telemedicine intervention in adult (18+) 
patients with heart failure in the outpatient setting. Among these studies, four of them 
evaluated the use of a non-invasive telemonitoring system that transmitted patient data to 
the healthcare team (Koehler et al., 2018; Kraai et al., 2016; Long et al., 2017; 
Pekmezaris et al., 2018). There were two studies that evaluated the use of structured 
telephone support and non-invasive home telemonitoring devices (Inglis et al., 2015; 
Pedone et al., 2015). Son et al. (2020) utilized mobile phone-based interventions, which 
included voice call, telemonitoring, and short message services (SMS). A MedSentry 
remote medication monitoring system was evaluated in heart failure management in the 
Hale et al. (2016) study. Kotb et al. (2015) evaluated the use of telephone support with 
telemonitoring, video monitoring, and electrocardiogram (ECG) monitoring. The final 
study evaluated the effectiveness of health coaching telephone calls along with 
telemonitoring (Ong et al., 2016).  
The primary end outcomes of a majority of the studies included all-cause 
hospitalizations, heart failure-related hospitalizations, all-cause mortality, and heart 
failure-related mortality (Hale et al., 2016; Inglis et al., 2015; Koehler et al., 2018; Kotb 
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et al., 2015). Ong et al. (2016) assessed all-cause readmissions within 30 and 180 days 
from hospital discharge, all-cause mortality at 30 and 180 days, and quality of life at 30 
and 180 days. Long et al. (2017) was the only other study that evaluated the impact of 
telemonitoring on 30-day hospital readmissions. Pekmezaris et al. (2018) specifically 
assessed all-cause mortality at 180 days and 365 days, all-cause hospitalizations at 90 and 
180 days, and heart failure-related hospitalizations at 180 days. Pedone et al. (2015) also 
assessed hospital readmissions and mortality at 180 days. In the Koehler et al. (2018) 
study, percent of days lost as a result of an unplanned admission and mortality were also 
evaluated. Additional outcomes assessed in the Inglis et al. (2015) study included hospital 
length of stay (LOS), health-related quality of life (HRQL), heart failure knowledge and 
self-care, acceptability, and costs. Emergency department (ED) visits, medication 
adherence, and HRQL were additional outcomes assessed in the Hale et al. (2016) study. 
Furthermore, Kraai et al. (2016) evaluated the total and duration of hospital admissions as 
well as the number of outpatient visits to the heart failure clinic, change in HRQL, and 
cost analyses.  
Synthesis of Research on Hospitalization and Readmissions 
Hale et al. (2016) demonstrated a significant decrease in the rate of all-cause 
hospitalizations and hospital LOS in the intervention arm compared to the control. 
However, there were no differences noted in regard to ED visits as well as heart failure-
related and non-heart failure-related hospitalizations (Hale et al., 2016). In the Inglis et al. 
(2015) systematic review, both non-invasive telemonitoring and structured telephone 
support lowered heart failure-related hospitalizations; however, there was no reduction in 
the risk of all-cause hospitalizations. Koehler et al. (2018) found that the remote 
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monitoring group had a lower percentage of days lost related to unplanned heart failure-
related readmissions. In the Kotb et al. (2015) systematic review and meta-analysis, there 
was no significant reduction in all-cause hospitalization among the intervention groups. 
However, there was a significant reduction in heart failure-related hospitalizations among 
the intervention groups, which included structured telephone support, telemonitoring, and 
telemedicine along with ECG transmission (Kotb et al., 2015). Additionally, reductions 
in hospitalizations were noted in the Pedone et al. (2015) study through the use of a 
physician-led telemonitoring program.  
In the systematic review and meta-analysis by Son et al. (2020), there were no 
significant reductions in hospital readmissions using mobile phone-based interventions. 
However, there was a significant reduction in hospital LOS (Son et al., 2020). The IN 
TOUCH study by Kraai et al. (2015) did not show significant benefits from the use of 
telemonitoring in preventing heart failure-related readmissions. The Long et al. (2017) 
systematic review showed mixed results. There were some differences noted regarding 
readmissions in some of the studies. However, these studies lacked an adequate sample 
size (Long et al., 2017). In the BEAT-HF study, there was no significant difference in all-
cause 30-day or 180-day readmissions using health coaching, telephone calls in addition 
to telemonitoring (Ong et al., 2016). All-cause hospitalizations at 90 and 180 days were 
not impacted by telemonitoring in the Pekmezaris et al. (2018) systematic review and 
meta-analysis. Additionally, Pekmezaris et al. (2018) identified that heart failure-related 
hospitalizations at 180 days were not significantly reduced in the intervention group. 
Synthesis of Research on Mortality 
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In the Inglis et al. (2015) systematic review, all-cause mortality was lowered 
using non-invasive telemonitoring and structured telephone support. The TIM-HF2 study 
by Koehler et al. (2018) demonstrated a decreased percentage of days lost as a result of 
all-cause mortality in the remote monitoring group compared to the standard care group. 
However, no significant difference was noted in the percentage of days lost as a result of 
heart failure-related mortality (Koehler et al., 2018). The systematic review and meta-
analysis by Kotb et al. (2015) identified that both structured telephone support as well as 
telemonitoring significantly lowered the risk of all-cause mortality among the 
intervention groups; however, this was more notable among the telemonitoring group. 
There were no significant differences noted between the groups using the other 
telemedicine interventions on all-cause mortality (Kotb et al., 2015). In the Long et al. 
(2017) systematic review, there was a 50% reduction in mortality among the 
telemonitoring group in one of the studies included in the review. The systematic review 
and meta-analysis by Pekmezaris et al. (2018) noted a 40% decrease in 180-day all-cause 
mortality in the telemonitoring group. Additionally, two studies demonstrated a 61% 
reduction in heart failure-related mortality at 180 days (Pekmezaris et al., 2018). 
However, there was no significant reduction in all-cause mortality at 365 days 
(Pekmezaris et al., 2018). The physician-led, telemonitoring program in the Pedone et al. 
(2015) study also demonstrated effectiveness in reducing 180-day mortality. Moreover, 
the systematic review and meta-analysis by Son et al. (2020) found a reduction in risk of 
mortality using mobile phone-based interventions; however, pooled results demonstrated 
low heterogeneity. The IN TOUCH study by Kraai et al. (2015) did not find any 
significant benefits related to all-cause mortality in the telemonitoring group. Lastly, 
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there were no differences in 180-day all-cause mortality noted between the groups in the 
BEAT-HF study (Ong et al., 2016).  
Quality Indicators and Strength of Search 
 The search methods employed for this literature review were comprehensive in 
nature. Search results were reviewed for level of evidence and critically appraised for 
inclusion in this review. The research articles utilized for this review were limited to peer 
reviewed articles from scholarly, academic journals. Furthermore, articles were limited to 
level I or II evidence according to the hierarchy of evidence (Melnyk and Fineout-
Overholt, 2019).  
Gaps and Limitations  
Lack of an adequate sample size was a common theme identified in many of the 
studies that were included (Kraai et al., 2016). Hale et al. (2016) mention issues with 
poor recruitment, thus, leading to small sample size. Additionally, poor adherence to the 
telemonitoring interventions was noted among participants in the BEAT-HF study (Ong 
et al., 2016). In the study by Hale et al. (2016), significant differences in baseline 
characteristics consisting of the New York Heart Association (NYHA) classification of 
heart failure and HRQL were noted among the participants. Another gap identified in the 
literature was the exclusion of individuals likely at increased risk for 30-day readmissions 
(Long et al., 2017). Additionally, the subpopulation(s) of heart failure patients that would 
most benefit from telemedicine interventions have been ill-defined (Kotb et al., 2015). 
Long et al. (2017) mention the inconsistencies and lack of standardized design protocols 
among telemonitoring systems leading to poor intervention fidelity. Many previous 
studies also only broadly assess the effects of telemedicine interventions in comparison to 
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usual care (Kotb et al., 2015). Additionally, the available research comparing 
telemedicine interventions is limited (Kotb et al., 2015). Moreover, studies are 
consistently focused on telephone support and telemonitoring interventions in the heart 
failure population with research lacking in other areas such as video monitoring and ECG 
monitoring (Kotb et al., 2015). Long et al. (2017) specifically mentions the lack of 
research evaluating the impact of telemedicine interventions on 30-day readmission rates. 
A comparison of the cost-effectiveness between the various telemedicine interventions is 
also not well known (Kotb et al., 2015). Lastly, the long-term clinical significance of 
telehealth interventions on heart failure readmissions and hospitalizations is poorly 
understood (Hale et al., 2016; Kotb et al., 2015).  
Discussion 
The findings from this review demonstrated mixed results. Hale et al. (2016) 
noted a significant reduction in all-cause hospitalizations as well as decreased hospital 
LOS in the intervention group compared to the standard care group with the use of the 
MedSentry medication monitoring system. However, Hale et al. (2016) also noted a 
significant reduction in HRQL in the intervention arm. This may be attributed to the 
reduced heart failure class and heart function among the intervention participants (Hale et 
al., 2016). Overall, findings from the Hale et al. study demonstrate the potential benefits 
of implementing medication adherence, telehealth technologies. The systematic review 
by Inglis et al. (2015) identified the benefits of structured telephone support as well as 
non-invasive home telemonitoring in decreasing the risk of all-cause mortality and heart 
failure-related hospitalizations. These interventions were also found to help improve 
HRQL, knowledge about heart failure, and self-care behaviors among study participants 
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(Inglis et al., 2015).  Koehler et al. (2018) found a significant reduction in the number of 
days lost due to unplanned hospitalizations as well as a decrease in all-cause mortality 
using a structured remote monitoring intervention. There were no improvements noted in 
HRQL using the telemonitoring intervention (Koehler et al., 2018). This could be related 
to major depression being part of the exclusion criteria (Koehler et al., 2018). In the Kotb 
et al. (2015) systematic review and meta-analysis, structured telephone support and 
telemonitoring decreased heart failure-related hospitalizations and risk of mortality 
compared to usual care. Additionally, ECG monitoring decreased heart failure 
hospitalizations (Kotb et al., 2015).  
The Pedone et al. (2015) study evaluated the use of a telemonitoring system in 
patients 65 and older and found that this intervention resulted in decreased risk of all-
cause mortality and hospitalization. In the systematic review and meta-analysis by 
Pekmezaris et al. (2018), findings included a significant reduction in heart failure-related 
mortality and all-cause mortality at 180 days when home telemonitoring was used. 
However, Pekmezaris et al. (2018) also noted that the study findings were time dependent 
and found that there were no significant reduction in odds at 365 days. Factors that may 
account for this include worsening of the disease and poor long-term patient adherence 
(Pekmezaris et al., 2018). There were no significant reductions in heart failure-related 
hospitalizations or all-cause hospitalizations observed in the study (Pekmezaris et al., 
2018). 
Kraai et al. (2015) found no significant reduction in heart failure admissions and 
all-cause mortality in the intervention group. The reason for this could be that the 
population included in the study sample was relatively healthy (Kraai et al., 2015). 
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Although no significant differences were noted in the IN TOUCH study, Kraai et al. 
(2015) mention there was a significant decrease in outpatient visits to the heart failure 
clinic. Additionally, there was a high rate of adherence to the telemonitoring intervention 
(Kraai et al., 2015). This suggests that telemonitoring may be a safe alternative to 
outpatient clinic visits and may help to improve accessibility to healthcare (Kraai et al., 
2015). In the systematic review by Long et al. (2017) there were four studies that 
demonstrated a difference in readmission rates among heart failure patients; however, 
three of the studies lacked an adequate sample size to provide statistical significance. Ong 
et al. (2016) did not find a significant benefit from using health coaching, telephone calls 
and telemonitoring on readmissions or mortality. Although, there was significant 
improvement noted in HRQL at 180 days (Ong et al., 2016). However, Ong et al. (2016) 
state that further research is needed to validate these study findings.  
Lastly, the systematic review and meta-analysis by Son et al. (2020) did not 
demonstrate a significant reduction in hospital readmissions using mobile phone-based 
interventions. However, hospital LOS was significantly reduced using the voice call 
intervention (Son et al., 2020). One study in the Son et al. (2020) systematic review and 
meta-analysis showed a statistically significant difference in disease prevention, lifestyle 
modifications, and disease management among the intervention group. There was no 
significant benefit noted with the other mobile phone-based interventions on reducing all-
cause mortality, readmissions, ED visits, or improving HRQL (Son et al., 2020). 
However, Son et al. identified inconsistencies with the mobile phone-based interventions 
among the studies. Thus, pointing to the fact that variations in the intervention frequency, 
intensity, duration, and feedback provided attributed to these inconsistencies. Son et al. 
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also mention that the SMS interventions were one-way messages and not interactive. 
Additionally, the difficulties that some populations may have with these interventions, 
specifically among the elderly population, may have been an issue (Son et al., 2020).  
Implications for Future Practice 
The current literature was evaluated through this literature review and 
recommendations for future direction were made. A compilation of recommendations for 
clinical practice, future research, education, and policy follow.  
Clinical Practice Recommendations 
A wide variety of telemedicine interventions are available for use in the 
management of heart failure. Although the results of this literature review were mixed, 
telemedicine may be beneficial in improving health outcomes, such as reducing visits to 
the heart failure clinic, preventing readmissions, and decreasing days lost as a result of 
hospitalization and mortality (Hale et al., 2016; Inglis et al., 2015; Koehler et al., 2018; 
Kotb et al., 2015; Kraai et al., 2015; Pedone et al., 2015; Pekmezaris et al., 2018; Son et 
al., 2020). Additionally, telemedicine may help to increase access to healthcare services 
and improve the HRQL among heart failure patients (Inglis et al., 2015; Kraai et al., 
2015; Long et al., 2017; Pekmezaris et al., 2018). Furthermore, telemedicine may 
improve heart failure knowledge and education as well as disease management and self-
care behaviors among patients with heart failure (Inglis et al., 2015; Ong et al., 2016; Son 
et al., 2020). Given the current pandemic and more widespread use of telehealth 
technologies, advanced practice providers should be knowledgeable and adept at utilizing 
telehealth and telemedicine interventions. Additionally, providers should be skilled in 
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tailoring interventions to the specific population and age group they are serving while 
keeping patient preferences in mind.  
Recommendations for Future Research  
Future studies specific to the use of telehealth interventions in the heart failure 
patient population should focus on gaps and limitations identified in the literature. Small 
sample size was a commonly identified limitation (Hale et al., 2016; Pedone et al., 2015; 
Son et al., 2020). Subsequently, further studies merit a larger sample size to provide 
greater power to the study and to fully appreciate outcomes (Hale et al., 2016; Pedone et 
al., 2015). Additionally, Long et al. (2017) mentions a meta-analysis would be beneficial 
to evaluate and compare the design of telemonitoring modalities.  
Kotb et al. (2015) point out that previous studies have only broadly assessed the 
effects of telemedicine in comparison to usual care and the available research comparing 
telemedicine interventions to each other is limited. Therefore, future studies should 
provide a comparison of the effectiveness of these various modalities (Inglis et al., 2015; 
Kotb et al., 2015). Kotb et al. (2015) also mention that a major focus of current research 
has been on telephone support and telemonitoring interventions. Newer telemedicine 
technologies, such as implantable devices, may be beneficial in improving patient 
engagement and adherence as well as providing more detailed health status information 
(Ong et al., 2016). Thus, it is pertinent that future studies be conducted utilizing the most 
current technologies as well as a broad range of modalities available in telemedicine such 
as video monitoring and ECG monitoring (Inglis et al., 2015; Kotb et al., 2015). Inglis et 
al. (2015) also discuss needing further research in utilizing closed-loop systems, which 
incorporates physiological measurements into decision-support tools.  
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Long et al. (2017) mentions the inconsistencies and lack of standardized design 
protocols among telemonitoring systems leading to poor intervention fidelity. Inglis et al. 
(2015) emphasizes the importance of developing a standardized design for future studies 
as well as reporting criteria. Areas for future research should also include testing all 
elements of interventions including duration (Pekmezaris et al., 2018). Additionally, 
studies should specify whether single interventions or multiple interventions are most 
effective (Son et al., 2020). Future studies should also focus on telemedicine and its 
effectiveness at specifically reducing 30-day readmissions (Long et al., 2017). Moreover, 
the long-term clinical significance of various telehealth interventions on heart failure 
outcomes should be addressed (Hale et al., 2016; Kotb et al., 2015). 
Previous studies have extensively evaluated health outcomes; however, there is 
limited data on economic and societal outcomes including increasing access to care and 
reducing disparities among heart failure populations (Inglis et al., 2015; Pedone et al., 
2015; Pekmezaris et al., 2018). A cost-analysis and comparison of various telemedicine 
interventions should also be an area of focus in future research (Inglis et al., 2015; Kotb 
et al., 2015; Pedone et al., 2015). Moreover, the full benefits of telemonitoring should be 
assessed including length and quality of life, reduced travel for patients and healthcare 
providers, and improved provider efficiency (Pekmezaris et al., 2018).  
In the Hale et al. (2016) study, significant differences were noted among 
participants in regard to the NYHA classification of heart failure and HRQL. Thus, it is 
suggested that further studies obtain a larger sample size or utilize inclusion and 
exclusion criteria that would provide a narrower range of baseline characteristics (Hale et 
al., 2016; Pedone et al., 2015). In the Pedone et al. (2015) study, there were significant 
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physical impairments noted among the participants in the sample size; therefore, making 
generalizability difficult (Pedone et al., 2015). Moreover, a gap identified in the Long et 
al. (2017) study was the exclusion of individuals most likely at increased risk for 30-day 
readmissions, such as non-English speaking patients or patients with cognitive 
impairments. An area of focus for future studies should be on identifying specific 
subpopulations of heart failure patients that would most benefit from the telemedicine 
interventions (Kotb et al., 2015). Inglis et al. (2015) also identify the potential benefits of 
telemonitoring among heart failure patients during end-of-life. Furthermore, the target 
age of the participants in future studies should be considered as well as patient 
preferences (Inglis et al., 2015; Son et al., 2020). 
Education Recommendations  
There is an increasing need to identify methods effective at improving heart 
failure health outcomes and reducing the burden of heart failure on healthcare costs and 
utilization. As innovative telemedicine methods become more prevalent and widely used, 
healthcare providers need to be trained to competently utilize telehealth, telemonitoring, 
and telemedicine measures to care for various patient populations. Additionally, the 
identification of methods to disseminate research findings related to best practices in 
heart failure management is necessary.  
Recommendations for Policy 
Pekmezaris et al. (2018) state that regulation issues, problems with 
reimbursement, and other policy issues have hindered the widespread use of telemedicine 
in heart failure management. Pekmezaris et al. (2018) also mention that the recent 
changes in regulations that relaxed Medicare restrictions of telemedicine only address 
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videoconferencing reimbursements and do not address vital signs monitoring. Further 
loosening of restrictions pertaining to reimbursement for telehealth services as well as 
expansion of telehealth services should remain a priority (Pekmezaris et al., 2018).  
Conclusion 
The findings from this systematic literature review contribute to the current 
knowledge related to the impact of telemedicine in the heart failure population. Although 
the findings from this literature review provide mixed results, telemedicine modalities 
have the potential to improve outcomes among heart failure patients as well as reduce the 
burden on costs and healthcare utilization. Advanced practice providers can utilize the 
knowledge provided from this literature review to improve the care of heart failure 
patients. Furthermore, findings from this literature review have provided implications for 
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